Perez, C. A., Gandhi, N. J., Mosalpuria, K., Cowey, C. L., Hodgson, I., Smethurst, D., Pinato, D. J. (2025). Phase I dose-escalation study of the next-generation nectin-4 targeting antibody–drug conjugate CRB-701 (SYS6002) in US and UK patients with urothelial cancer and other solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.807